52 studies found for:
Pamidronate
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Completed |
A Pilot Trial of IV Pamidronate for Low Back Pain
|
||||
| 2 | Unknown † |
A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
|
||||
| 3 | Completed |
Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
|
||||
| 4 | Active, not recruiting |
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
|
||||
| 5 | Completed |
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
|
||||
| 6 | Recruiting |
Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
|
||||
| 7 | Completed |
Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
|
||||
| 8 | Completed |
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
|
||||
| 9 | Recruiting |
Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease
|
||||
| 10 | Withdrawn |
Study of Pamidronate for the Prevention of Heterotopic Ossification
|
||||
| 11 | Completed |
A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
|
||||
| 12 | Completed |
Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
|
||||
| 13 | Active, not recruiting |
Pamidronate to Treat Osteogenesis Imperfecta in Children
|
||||
| 14 | Active, not recruiting |
Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
|
||||
| 15 | Unknown † |
Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
|
||||
| 16 | Unknown † |
Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty
|
||||
| 17 | Completed |
Prevention of Post Operative Bone Loss in Children
|
||||
| 18 | Completed |
Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
|
||||
| 19 | Active, not recruiting |
Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
|
||||
| 20 | Terminated |
Prevention of Steroid-Induced Osteoporosis in Children
|
† Indicates status has not been verified in more than two years
